Get started
BioCorRx Inc.BioCorRx Inc.BioCorRx Inc.

BioCorRx Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals

BICX chart

Upcoming earnings

Next report date
Report period
Q1 2024
EPS estimate
—
Revenue estimate
—

Key stats

Market capitalization
‪7.23 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.4531USD
Net income (FY)
‪−3.77 M‬USD
Revenue (FY)
‪89.16 K‬USD
Shares float
‪2.93 M‬
Beta (1Y)
−1.36

About BioCorRx Inc.

Sector
Health Services
Industry
Hospital/Nursing Management
CEO
Lourdes Felix
Website
biocorrx.com
Headquarters
Anaheim
Employees (FY)
3
Founded
2008
FIGI
BBG000Q351D2
BioCorRx, Inc. engages in the provision of alcoholism and opioid addiction treatment. It offers treatment philosophy that combines medical intervention and a proprietary cognitive behavioral therapy program specifically tailored for the treatment of alcoholism and other substance abuse addictions for those receiving long-term naltrexone treatments. It also engages in the research and development of sustained release naltrexone products for the treatment of addiction and other possible disorders. The company was founded by Neil Terrence Muller and George O'Neill on January 28, 2008 and is headquartered in Anaheim, CA.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of BICX is 0.7500 USD — it has decreased by 8.54% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange BioCorRx Inc. stocks are traded under the ticker BICX.
BioCorRx Inc. is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
BICX stock is 36.00% volatile and has beta coefficient of −1.36. Check out the list of the most volatile stocks — is BioCorRx Inc. there?
Yes, you can track BioCorRx Inc. financials in yearly and quarterly reports right on TradingView.
BICX stock has fallen by 49.32% compared to the previous week, the month change is a 9.09% fall, over the last year BioCorRx Inc. has showed a 57.87% decrease.
BICX net income for the last quarter is ‪−968.54 K‬ USD, while the quarter before that showed ‪−866.28 K‬ USD of net income which accounts for −11.80% change. Track more BioCorRx Inc. financial stats to get the full picture.
Today BioCorRx Inc. has the market capitalization of ‪7.71 M‬, it has decreased by 48.98% over the last week.
No, BICX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BICX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BioCorRx Inc. stock right from TradingView charts — choose your broker and connect to your account.
BICX reached its all-time high on Aug 31, 2010 with the price of 95.0000 USD, and its all-time low was 0.1550 USD and was reached on Dec 23, 2020.
See other stocks reaching their highest and lowest prices.
As of Apr 27, 2024, the company has 3.00 employees. See our rating of the largest employees — is BioCorRx Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BioCorRx Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BioCorRx Inc. stock shows the sell signal. See more of BioCorRx Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BioCorRx Inc. EBITDA is ‪−3.54 M‬ USD, and current EBITDA margin is ‪−3.97 K‬%. See more stats in BioCorRx Inc. financial statements.